Table 1.
Management and mechanisms of KOA.
| Management of KOA | Mechanisms of KOA | |||
|---|---|---|---|---|
| Pharmaceutical approaches | Non-pharmaceutical approaches | Surgical management | Pathogenesis | Molecular mechanisms of KOA |
| NSAIDS | Health education | OAK | Excessive proliferation of chondrocytes | MMPs, ADAMTS↑ |
| Analgesics | Regular exercise including aerobic, strengthening, and resistance exercises | UKA | Abundance of ECM | IL-1β, IL-6, TNF-α↑ |
| Glucocorticoids | Weight loss | TKA | Synovial inflammation | NF-κB, MAPK, PI3K/Akt signaling pathway |
| Targeted therapy strategies | Physical therapy including therapeutic ultrasound, electrical stimulation, phototherapy, hydrotherapy, magnet therapy, acupuncture and moxibustion | – | Breakdown of cartilage tissue | – |
ADAMTS = a disintegrin and metalloproteinase with thrombospondin motifs, ECM = extracellular matrix, IL-1β = interleukin-1, IL-6 = interleukin-6, KOA = knee osteoarthritis, MMPs = matrix metalloproteinases, NSAIDs = nonsteroidal anti-inflammatory drugs, OAK = osteotomy around the knee, TKA = total knee arthroplasty, TNF-α = tumor necrosis factor-alpha, UKA = uknee arthroplasty.